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Abstract.  Pemphigus vulgaris antigen (PVA) is a 
member of the desmoglein subfamily of cadherin cell 
adhesion molecules. Because autoantibodies in this 
disease cause blisters due to loss of epidermal cell 
adhesion,  and because desmoglein is found in the des- 
mosome cell adhesion junction,  we wanted to deter- 
mine if PVA is also found in desmosomes. By im- 
munofluorescence, PV IgG bound, in a dotted pattern, 
to the cell surface of cultured human keratinocytes in- 
duced to differentiate with calcium,  suggesting junc- 
tional staining.  However, by preembedding,  im- 
munogold electron microscopic studies only slight 
labeling could be detected in desmosomes, presumably 
because of difficulty in gold penetration of intact des- 
mosomes. We therefore treated the keratinocytes with 
0.01% trypsin in  1 mM calcium,  conditions known to 
preserve cadherin antigenicity but that caused slight 
separation of desmosomes, before immunogold stain- 
ing.  In this case there was extensive labeling of the ex- 
tracellular part of desmosomes but not of the interdes- 
mosomal cell membrane which was stained with 
anti-/32-microglobulin antibodies.  To confirm the 
specificity of this binding we showed that antibodies 
raised in rabbits against the extracellular portions of 
PVA also bound desmosomes in these cultures.  In in- 
tact mouse epidermis we could also show slight,  but 
specific, immunogold desmosomal labeling with PV 
IgG.  Furthermore,  neonatal mice injected with PV 
IgG affinity purified on PVA showed desmosomal 
separation with the IgG localized to desmosomal 
cores.  These results indicate that PVA is organized and 
concentrated within the desmosome where it presum- 
ably functions to maintain  the integrity of stratifying 
epithelia. 
p 
EMPHIGUS vulgaris  (PV) ~ is an autoimmune disease 
in which blisters of skin and mucous membranes re- 
sult from loss of epithelial  cell-to-cell adhesion,  a 
pathologic process called acantholysis  (31). Immunofluores- 
cence studies demonstrate that PV patients have IgG bound 
on their epidermal cell surfaces in vivo and also have cir- 
culating IgG that binds to the cell surface of normal stratified 
squamous epithelia  (5,  6).  These PV autoantibodies have 
been shown to be pathogenic by both clinical and experimen- 
tal observations (for review see reference  29). 
The antigen  (PVA) recognized by PV autoantibodies has 
been characterized by immunochemical  methods.  Immuno- 
precipitation  of cultured keratinocyte and  normal  human 
epidermal extracts demonstrates that PV sera bind a 130-kD 
glycoprotein which forms a  stoichiometric  complex with 
plakoglobin (22),  a plaque protein of intercellular  adhering 
junctions (i.e., desmosomes and adherens junctions) (8). 
Recent eDNA cloning  has demonstrated that the PVA is 
a member of the cadherin  supergene  family (3). The origi- 
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nally described or classical cadherins  (called E-cadherin  or 
uvomorulin,  L-CAM,  N-cadherin,  and  P-cadherin)  are  a 
family of cell adhesion molecules with certain functional and 
structural  similarities  (7, 36, 37). They are transmembrane 
molecules  that  mediate  calcium-dependent,  homophilic 
adhesion and share the interesting property that they are pro- 
tected from trypsin degradation  by calcium.  The classical 
cadherins  have been described to be found concentrated in 
adherens junctions. 
Another subfamily within the cadherin superfamily  is the 
desmogleins.  Desmoglein was orginally identified as a trans- 
membrane glycoprotein of desmosomes (12, 25, 26). Recent 
eDNA cloning studies have shown that desmogleins are actu- 
ally a gene family of tbeir own (7, 19, 20) and have homology 
to the orginally described cadherins,  both in their extracellu- 
lar amino-terminal  region and in part of their cytoplasmic re- 
gion (11, 21, 23,  39).  The amino acid sequence of PVA is 
more closely related to the desmogleins than to the classical 
cadherins,  both in the cytoplasmic region (which  contains 
the "desmoglein-specifiC  repeating motif and cysteines) and 
in the extracellular  domains (3). 
Because antibodies against  PVA cause loss of epidermal 
cell adhesion and  because PVA is closely related  to des- 
mogleins,  we speculated that PVA, like desmoglein,  might 
be organized into the desmosome type of cell adhesion june- 
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been contradictory. Immunofluorescence studies of mouse 
keratinocytes in culture have suggested that PV antibodies 
might bind desmosomes (16). In addition, immunoblot stud- 
ies of bovine desmosomes demonstrate that a '~130-kD anti- 
gen is  detected with PV  sera  (13, 16).  However,  by im- 
munoperoxidase  staining  of  PV  patients'  skin,  IgG  is 
distributed diffusely along the keratinocyte cell membrane 
(40).  In addition, ultrastructural localization of PVA by in- 
direct immunoferritin on trypsinized guinea pig keratino- 
cytes, by immunoperoxidase staining of skin from neonatal 
mice injected with PV IgG, and by immunogold staining of 
bovine  tongue  with  a  rabbit  antibody  raised  against  a 
presumptive PVA from bovine tongue desmosomes all re- 
vealed PVA distributed diffusely along the cell membrane 
and not concentrated in desmosomes (17, 35, 38).  However, 
contrary ultrastructural localization results, that showed PV 
IgG  predominantly  in  desmosomes,  were  obtained  by 
immunoferritin detection of IgG on patients' skin (14) and by 
immunogold localization of PV serum binding on cultured 
squamous cell carcinoma keratinocytes (I). 
The purpose of this study was to definitively determine if 
PVA is predominantly found in desmosomes. We took ad- 
vantage of the information from recent cloning of the PVA 
cDNA in order to perform ultrastructural localization stud- 
ies. Because of the unique property of cadherins to resist 
trypsinization in the presence of calcium, we studied ker- 
atinocytes whose desmosomes were made more accessible 
to gold-labeled probes by this treatment. In addition, for in- 
creased specificity we affinity purified human antibodies, 
and raised rabbit antibodies, with extraceUular portions of 
the PVA, and used these antibodies for immunolocalization. 
Our results show that PVA is found predominantly in ker- 
atinocyte desmosomes. 
Materials and Methods 
Patient Sera, Antibodies, and Rabbit Antisera 
Sera from five patients with PV were used. Each serum immunoprecipitated 
the characteristic PVA complex (containing the 130-kD antigen) from ex- 
tracts of normal epidermis or cultured keratinocytes (9, 33). This immuno- 
precipitation has been shown to be specific for PV patient sera (9, 33). 
Antibodies from the sera of two of the PV patients were affinity purified 
on/~-galactosidase fusion proteins made, as previously described, from 
cDNA cloned into the pUEX 1 plasmid and encoding all of the two most 
amino-terminal extracellular domains of PVA, as well as part of the third 
domain (2). This region of PVA is referred to as EC1-2 (see reference 2 for 
details). 
Antibodies were raised in rabbits against ~-gaiactosidase fusion proteins 
containing EC1-2 or the most amino-terminal extracellular domain (termed 
EC1). The production of  these fusion proteins has been previously described 
in detail (2). Rabbits were immunized subcutaneously at multiple sites with 
,,o500 #g of insoluble fusion protein mixed with complete (first injection) 
or incomplete Freund's adjuvant every 2 wk for a total of five injections. 
For the last two boosts the fusion proteins were first solubilized in 8 M urea 
then dialyzed against 10 mM Tris-HCl pH 7.6. 
A rat mAb, ECCD-2, against the extracellular region of E-cadherin and 
a mouse mAb, HECD-I, against human E-cadherin were kindly provided 
by Dr. M. Takeicbi (27, 28). An affinity purified rabbit antibody against/~2- 
microglobulin was purchased (Boehringer-Manulaeim Corp., Indianapolis, 
IN). A rabbit polyclonal antibody against desmoglein isolated from bovine 
snout was kindly provided by Dr. M. S. Steinberg (10), and a mouse mAb, 
DG3.10,  against desmoglein was obtained commercially (IBL Research, 
Cambridge, MA) (25). 
Kerafinocyte Cell Culture and Fixation 
Normal human epidermal keratinocytes were cultured in media containing 
0.15 mM calcium (Clonetics, San Diego, California) and subcultured into 
cell culture chamber slides (Lab-Tek,  Nunc Inc., Naperville, IL). When 
subcultures were almost confluent, the calcium concentration was raised to 
2 mM for 24 h to induce synthesis of PVA (3, 34). In some experiments, 
subcultures were then incubated at room temperature with Hanks-Hepes so- 
lution (Gibco-BRL, Grand Island, NY) containing 0.01% trypsin (1:250) 
(Gibco-BRL, 1 gm digests 250 gm casein at 25"C for 10 rain, pH 7.6) and 
1 mM Ca, for 20-30 rain, in order to separate desmosomal junctions to 
allow penetration of immunogold reagents. Both trypsin-treated and un- 
treated cells were fixed in 2 % paraformaldehyde in PBS for 10 rain. Cells 
were then processed for immunofluorescence or immunoelectron micro- 
scopic studies. 
Immunoblotting and Immunoprecipitation 
Immunoblotting was performed, as previously described (3), on extracts of 
cultured human keratinocytes induced to differentiate with high calcium, as 
described above. 
Immunoprecipitation was performed on cell extracts of these keratino- 
cytes after metabolic labeling with  [35S]methionine/cysteine  (NEN  Ex- 
press, Dupont, Boston, MA) for 2-24 h. In some experiments cells were 
extracted with 1% Nonidet P-40,  1% Triton X-100, 2 mM CaC12, in TBS 
(10 mM Tris-HCl, 0.15 M NaC1, pH 7.4). After adding BSA to a final con- 
cent.ration of  0.1%, these extracts were preabsorbed with normal human and 
mouse sera and protein G sepharose (Sigma Chemical Co., St. Louis, MO). 
Immunoprecipitation was performed with 10/xl of serum or 10 #g of mAb 
incubated overnight at 4°C, then 25 #1 of protein G incubated for 1 h. Im- 
munoprecipitates were washed 5 times with 0.5 % Triton X-100 in TBS, and 
precipitated complexes were eluted in SDS gel sample buffer and electro- 
phoresed as previously described (32). In some experiments, the labeled 
cells were extracted with 1% SDS, 8 M urea in TBS.  These extracts were 
dialyzed against 0.3% Nonidet P-40, 2 mM CaC12 in TBS to remove the 
denaturants, then immunoprecipitation was performed with protein A as 
previously described (32). 
Immunofluorescence 
Fixed cultured human keratinocytes were incubated for 45 rain at room tem- 
perature with human sera, rabbit antibodies or mAbs diluted 1:10 to  1:50 
in PBS. After washing extensively with PBS, the appropriate second anti- 
body, diluted in PBS, was applied for 30 rain. Second antibodies included: 
FITC- or biotin-conjugated affinity purified F(alY)2 anti-human, anti-rabbit 
or anti-rat IgG ('Ihgo, Burlingame, CA). Biotinylated antibodies were de- 
veloped with streptavidin-Texas  red (Tago)  or streptavidin-FITC (Vector 
Laboratories, Burlingame, CA). 
Neonatal Mouse Model of  Peraphigus Vulgaris 
Two newborn Balb/c mice were injected subcutaneously with IgG precipi- 
tated with ammonium sulfate from PV sera, and three mice were injected 
with PV IgG affinity purified on EC1-2,  as recently described (2). 
Immunoelectron Microscopy 
Cultured keratinocytes that were not treated with trypsin were fixed, as de- 
scribed above, then incubated overnight at 4"C with PV antibodies. After 
washing extensively with PBS the cells were incubated with  1 nm gold- 
labeled goat anti-human IgG for 2 h  at room temperature, washed, and 
postfixed in Karnovsky fixative.  The 1-nm gold was developed with silver 
enhancement (24).  Cultured keratinocytes that were treated with trypsin 
and fixed were incubated for 4 h or overnight with antibodies, washed, and 
incubated for 3 h at room temperature with the appropriate biotinylated sec- 
ond antibody. After additional washing, the chambers were incubated for 
3 h at room temperature with 5 nm streptavidin gold (Biocell, Ted Pella, 
CA). In some experiments, cells were doubly labeled by using gold-labeled 
(5 and 10 nm) anti-rabbit and anti-human antibodies (Biocell). All of these 
labeled cells were then washed, dehydrated in ethanol, and embedded in 
Epon 812  (EM Sciences, Washington, PA). 
Skin from neonatal mice injected with PV IgG was cut into small pieces 
(<1  ×  1 mm), incubated with biotinylated anti-human IgG (Vector Labora- 
tories) for 5 h at room temperature, washed with PBS, and incubated over- 
night at 4°C with 5 run gold-streptavidin (18). This method is referred to 
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ville, IL) then cut in a cryostat into 6-#m sections before incubation with 
5 nm gold-goat  anti-human IgG for 2 h at room temperature. This method 
is referred to as "cryosectioning." 
Skin from normal newborn mice was fixed with 2 % paraformaidehyde, 
then cut into small pieces and incubated  with PV IgG followed  by 1 nm gold 
goat anti-human  IgG as described above  (18). Gold  was visualized by silver 
enhancement. 
Thin sections were mounted on uncoated copper grids, stained in 2 % 
uranyl acetate and Reynold's  lead citrate, and examined with a Philips trans- 
mission electron microscope (model 400) operated at 80 kV. 
Results 
Immunofluorescence of  Differentiated  Cultured 
Keratinocytes  with PV Sera 
Normal human keratinocytes, cultured in high calcium to in- 
duce differentiation and PVA expression (3), were stained af- 
ter fixation by indirect immunofluorescence with 5 PV sera 
and 2  normal human sera.  PV IgG bound to these cells  in 
a  cell surface pattern that in some areas was resolved into 
a dot-like pattern,  suggesting junctional staining (Fig.  1 a). 
These findings confirm previous impressions of pemphigus 
antibody staining of cultured mouse keratinocytes (15,  16). 
Because we wanted to separate the desmosomes of these 
cells in order to permit gold penetration for immunoelectron 
microscopy (see below), we wanted to determine if PV anti- 
bodies would still bind after the keratinocytes were treated 
with 0.01%  trypsin in the presence of 1 mM calcium, condi- 
tions known to maintain intact the classical cadherins.  We 
first confirmed that antibodies to E-cadherin bound the cell 
surface  of these  keratinocytes  whether  or  not  they  were 
treated with trypsin/calcium (data not shown). Similarly, the 
staining pattern with PV sera of keratinocytes treated with 
trypsin/calcium was the same as that of keratinocytes with- 
out such treatment (compare Fig. 1, a and b). Normal human 
sera,  as controls,  showed no staining of these cells. 
Immunoelectron Microscopy with Human PV 
Antibodies on Cultured Keratinocytes 
Human keratinocytes cultured for 24 h in high calcium were 
fixed with 2 % paraformaldehyde before being used for im- 
munogold electronmicroscopy to localize the PVA with PV 
serum or PV IgG affinity purified on the EC1-2 extracellular 
domains of  PVA. Although there was excellent binding of  the 
PV antibodies  by immunofluorescence with  these  fixation 
conditions (see Fig. 1 a), there were few gold particles as de- 
tected by immunoelectron microscopy. What gold binding 
that was seen, however, was limited to desmosomes (data not 
shown).  No staining of desmosomes was seen with normal 
human serum or IgG. 
We speculated that the reason we saw such limited staining 
by immunogold in the face of such readily demonstrable PV 
antibody  binding  was  that  the  gold  particles  penetrated 
poorly into desmosomes where we hypothesized the  PVA 
was  predominantly  located.  To  circumvent  this  potential 
problem,  we exposed the keratinocytes to 0.01%  trypsin in 
1  mM  calcium.  These  conditions  preserved  the  PVA im- 
munoreactivity (Fig. 1 b) and resulted in markedly increased 
immunogold  binding  to  PVA  in  association  with  desmo- 
somes that were often separated (Figs. 2, 3). Normal human 
sera,  used  as  a  control,  did not show desmosome binding 
(Fig.  2  b).  Another control,  antibodies  against human/32- 
microglobulin,  showed binding to the cell surface between 
desmosomes, but not within desmosomes (Fig. 3). For these 
immunoelectron microscopic studies we used 4  PV sera,  2 
normal  human  sera,  and  one  rabbit  antisera  against  ~2- 
microglobulin. 
These immunoelectron microscopic results suggested that 
PVA is localized and concentrated in desmosomes. 
Production  and Characterization  of  Rabbit 
Anti-PVA Antibodies 
To confirm the specificity of our antibody staining with hu- 
Figure  1.  Immunofluores- 
cence of  human and rabbit an- 
tibodies  against  PVA on cul- 
tured  human  keratinocytes. 
Cells  were  either  fixed  di- 
rectly  in  2%  paraformalde- 
hyde  (a,  c)  or  treated  with 
0.01%  trypsin  in  1 mM  cal- 
cium  before  fixation  (b,  d) 
then  stained  with  PV  se- 
rum (a,  b),  rabbit antiserum 
against  PV EC1  (c) or EC1-2 
(d).  Note that rabbit anti-PV 
and human PV sera give simi- 
lar staining patterns with dot- 
ted fluorescence  in areas,  sug- 
gestive  of junctional binding. 
Treatment  with  trypsin/cal- 
cium does not change the in- 
tensity or pattern of staining. 
Bar,  20 #m. 
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of separated  desmosomes  in cultured  keratinocytes  treated  with 
trypsin/calcium  before fixation. (a) PV serum;  (b) normal human 
serum. Note gold localization to desmosomal cores, but not along 
the extradesmosomai membranes in a. (Arrow in a) Shows a "miss- 
ing" half-desmosome that is presumably turned out of the plane of 
section but is labeled by gold particles.  (Arrows  in b) Show a few 
gold  particles  nonspecifically  binding  the  cell membrane.  Bars, 
0.15 gm. 
Figure 4. Immunoblots of  extracts of cultured keratinocytes demon- 
strate that rabbit antibodies raised against extracellular regions of 
PVA bind the 130-kD PVA but not the homologous desmoglein. (a) 
Rabbit antibodies against EC1 and EC1-2 (c~EC1, c~EC1-2)  bind the 
130-kD PVA (arrow) identified by PV serum. (b) Rabbit antibodies 
bind the  130-kD PVA (arrows)  but do not bind the  160-kD des- 
moglein  (arrowheads) stained  by  anti-desmoglein  (aDG)  anti- 
bodies. 
Figure  3.  Double  immunogold  localization  of  PVA  and  /52- 
microglobulin to cultured kerafinocytes with desmosomes slightly 
separated by trypsin/calcium.  (a) 5 um gold indicates PVA; 10 um 
gold  indicates  ff2-microglobulin.  (b)  5  nm  gold  indicates  /32- 
microglobulin;  10 nm gold indicates PVA. Inserts in upper fight 
comer show separated desmosomes. Note that PVA is found in des- 
mosomes  but  ff2-microglobulin  is  found  along  the  extrades- 
mosomai cell membrane.  Bars, 0.1  tzm. 
man sera, we raised antibodies in rabbits against portions of 
the extracellular region of PVA. We immunized rabbits with 
/3-galactosidase  fusion  proteins  containing  either  the  two 
most  amino-terminal  extracellular  domains  of  PVA  and 
about one half of the third more proximal domain (called 
EC1-2), or the most amino-terminal extracellular domain it- 
self (EC1)  (2). We demonstrated by immunoblotting of ex- 
tracts of cultured keratinocytes that these antisera bound the 
130-kD PVA and did not cross-react with the homologous 
desmoglein  (Fig.  4).  In addition,  immunoprecipitation of 
nonionic detergent extracts of cultured keratinocytes showed 
that these rabbit antisera precipitated PVA but not E-cad- 
herin or desmoglein (Fig. 5 a, compare lanes 2, anti-E-cad- 
herin; lane 3, anti-desmoglein; lane 4, rabbit anti-EC1; lane 5, 
preimmune rabbit). Extraction of keratinocytes with harsher 
conditions  allows  more  desmoglein  to  be  extracted  and 
precipitated,  and  confirms that the  rabbit antisera do  not 
cross-react with desmoglein (Fig.  5  b:  lane 2,  rabbit anti- 
EC1-2,  lane 3,  rabbit anti-EC1, lane 4,  anti-desmoglein). 
Immunolocalization of  Rabbit Anti-PVA Antibodies 
By immunofluorescence of cultured keratinocytes, these rab- 
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PVA have the same ultrastructural localization to keratinocyte des- 
mosomes as does human PV IgG. Cultured human keratinocytes 
had the desmosomes separated with trypsin/calcium.  (a) Almost 
intact desmosomes stained with rabbit anti-EC1  antibodies (5 nm 
gold). (b) Slightly separated desmosome stained with rabbit anti- 
EC1 (5 um gold) and PV serum (10 nm gold), (c) Separated desmo- 
some stained by rabbit anti-EC1  (5 am gold) and PV serum (10 um 
gold). (d) Totally separated desmosome stained with rabbit anti- 
EC1-2 (5 um gold) and PV serum (10 nm gold). Bars, 0.2 #m. 
Figure 5. Immunoprecipitation of extracts of cultured keratinocytes 
demonstrate that PV IgG, affinity purified from patient serum, and 
rabbit anti-PVA  antibodies bind PVA, but not E-cadherin or des- 
moglein. (a) Nonionic detergent extracts. (Lane 1) affinity purified 
PV IgG; (lane 2) HECD-1 monoclonal antibody against E-cadherin 
(open circles show, from top, E-cadherin, c~ and/~ catenin); (lane 
3)  DG3.10 monoclonal anti-desmoglein (open circle shows des- 
moglein); (lane 4) rabbit anti-EC1;  (lane 5) preimmune rabbit se- 
rum; (lane 6) monoclonal anti-g[ control; (lane 7) normal human 
serum.  (Arrows show PVA and plakoglobin).  (b) To increase the 
amount of desmoglein (and other desmosomal proteins) extracted, 
the  cells  were extracted  with  SDS  and  urea,  which  was  subse- 
quently dialyzed out (see Material and Methods). (Lane 1 ) affinity 
purified PV IgG; (lane 2) rabbit anti-EC1-2;  (lane 3) rabbit anti- 
EC1; (lane 4) rabbit anti-desmoglein; (lane 5) normal human se- 
rum;  (lane 6) preimmune (for anti-EC1-2)  rabbit serum.  (Arrow 
shows desmoglein, arrowhead shows PVA). 
bit antibodies against EC1-2 and EC1 bound in a cell surface 
pattern with dotted staining, indistinguishable from the bind- 
ing  of human  PV  antibodies  (Fig.  1,  compare a  with  c,  b 
with d). 
Immunoelectron microscopy of cultured keratinocytes in- 
dicated that these rabbit antibodies and human PV antibod- 
ies,  colocalized to the desmosomes  (Fig.  6). 
Preimmune rabbit sera gave negative results in these im- 
munofluorescence  and immunoelectron microscopic proce- 
dures. 
Localization of PVA to Desmosomes in Mouse Skin 
The above studies demonstrate the localization of PVA in the 
desmosomes of cultured keratinocytes.  To determine if PVA 
is also localized to desmosomes in vivo, we performed im- 
munogold  electron microscopy on normal neonatal  mouse 
skin.  As in cultured cells, 5 or 10 nm gold did not penetrate 
into intact desmosomes of normal skin.  However, to try to 
show  PVA  in  intact  mouse  skin  we  used  PV  IgG affinity 
purified on EC1-2 and localized it by  1 nm gold with silver 
enhancement,  as we did with cultured keratinocytes whose 
desmosomes were intact. As with cultured keratinocytes, we 
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in desmosomes (data not shown). 
To increase access of gold to desmosomes, we used a neo- 
natal mouse model of PV. Mice injected with the total IgG 
that was precipitated with anamonium sulfate from human 
PV sera developed severe suprabasilar blistering, as previ- 
ously reported (2, 4). Electron microscopy revealed exten- 
sive suprabasilar acantholysis with basal cells maintaining 
their attachment to basement membrane. Immunolocaliza- 
tion of this IgG showed that gold particles did not penetrate 
to areas that were not blistered, but were concentrated on 
separated desmosomes as  well as  on internalized desmo- 
somes (data not shown). However, gold was also detected in 
clumps floating freely in the widened intercellular spaces as 
well as  in  vesicles surrounding internalized desmosomes. 
This type of gold localization, unassociated with any struc- 
tures,  suggested that extensive damage may have released 
PVA from cell surfaces or may have resulted in nonspecific 
aggregation of IgG. 
Therefore, in  order  to  minimize  the  extensive damage 
caused to the epidermis and to increase the specificity of the 
antibodies injected in these mice, we injected mice with PV 
IgG  affinity purified on the EC1-2  domain  of PVA.  This 
affinity purified IgG immunoprecipitated PVA but not E-cad- 
herin or desmoglein from extracts of cultured human ker- 
atinocytes (Fig. 5 a, compare lane I with lanes 2 and 3; Fig. 
5  b,  compare  lane  1  with  lane  4).  Affinity purification 
greatly  reduces  the  injection of IgG  that  is  not  directed 
against PVA and results in much less extensive blistering as 
judged by clinical examination and histology of the skin le- 
Figure  7.  Immunolocalization by cryosectioning (a)  or en bloc 
method (b, c) of human PV IgG affinity  purified on PVA ECI-2 and 
injected into neonatal mice. (a) Note extensive labeling on the sur- 
face of a split desmosome but not on the adjacent extradesmosomal 
membrane (arrows). (b) Note the gold stained haif desmosome at 
the right and a few gold particles at the edges of the closed desmo- 
somes (arrows), but no gold on the adjacent extradesmosomal cell 
membranes. (c) Gold labeling of half desmosomes but no labeling 
of the adjacent cell membranes. Bars, 0.2/~m. 
sions (2). Again, suprabasilar acantholysis was seen, but in 
general there was less extensive separation of  cells and better 
preservation of desmosomes, In this case, immunolocaliza- 
tion of PV IgG showed gold on the surface of separated des- 
mosomes but essentially none on extradesmosomal mem- 
branes  or  in  the  space  between  separated  keratinocyte 
membranes (Fig. 7). Again, there was no penetration of gold 
in areas where desmosomes remained intact. 
These in vivo studies, like the in vitro studies, show PVA 
localized in desmosomes. 
Discussion 
We used both an in vitro and in vivo system as well as several 
different antibodies and conditions to ultrastructurally local- 
ize PVA.  In all cases we found it within desmosomes. 
A potential problem with PVA immunolocalization studies 
is  that  PVA  and  cadherins,  particularly  desmoglein,  are 
closely related molecules (3). However, in this study we not 
only used patients' sera, but also used IgG from such sera 
affinity purified on PVA as well as rabbit sera raised against 
PVA.  By  immunoblotting  and  immunoprecipitation these 
antibodies bind PVA but not E-cadherin or desmoglein, and 
localize to the desmosome by immunoelectron microscopy. 
It should be noted that with almost any tissue preparation 
and fixation procedure it can be argued that there might be 
a selective loss of the antigen from extradesmosomal mem- 
branes but not from desmosomes. If such a loss did occur, 
the results still imply that PVA is organized into desmosomes 
and thus protected from destruction. However, we think such 
a selective loss is unlikely because: (a) we used two different 
methods  to  open  desmosomes-trypsin/calcium  for  ker- 
atinocytes and PV IgG-induced separation in neonatal mice; 
(b) in neonatal mice injected with affinity purified PV IgG, 
PVA was clearly localized to desmosomes in the early le- 
sions of limited disease; (c) in culture and epidermis, even 
without causing separation of desmosomes, gold tended to 
localize to desmosomes and  did not localize to  interdes- 
mosomal membranes. 
These studies extend our concept of  the desmoglein family 
of cadherins, which includes PVA. These molecules make up 
a family not only because of shared amino acid sequence ho- 
mology, but because they share other interesting similarities. 
The two known desmogleins (dsgl and dsg2) and PVA are 
all found on chromosome 18 (7). Both desmoglein and PVA 
bind plakoglobin, which is found in cell adhesion junctional 
plaques (22).  In humans,  autoantibodies against both des- 
moglein,  in pemphigus  foliaceus, and PVA,  in PV,  cause 
blisters of the epidermis due to loss of cell adhesion (30). 
Finally, as shown here, PVA,  like desmoglein, is localized 
predominantly in desmosomes. These similarities suggest a 
shared cell biologic function, probably related to cell adhe- 
sion in desmosomes, of this subfamily of cadherins. 
We thank Dr. Mark Udey for critically reviewing this manuscript and Drs. 
Masatoshi Takeichi and Malcolm Steinberg for providing antibodies. 
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